Results 11 to 20 of about 14,512 (238)
Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report [PDF]
Journal of Medical Case Reports, 2011 Introduction Central serous chorioretinopathy is characterized by serous neurosensory detachment of the macula and it usually resolves spontaneously with good visual prognosis.
Lai Timothy YY +2 more
doaj +4 more sources
SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY [PDF]
, 2015 PURPOSE: To evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, for nonresolving central serous chorioretinopathy. METHODS: This is a prospective, randomized, double-blinded, placebo-controlled crossover study. Sixteen eyes of
Elodie Bousquet +11 more
openalex +7 more sources
A review of acute central serous chorioretinopathy [PDF]
Reviews in Clinical Medicine, 2014 Central serous chorioretinopathy is a common cause of visual morbidity. It is characterized by idiopathic serous retinal detachment in macular or paramacular regions. The symptoms of the CSC include decreased vision, micropsia and metamorphopsia.
Mirnaghi Moosavi +2 more
doaj +3 more sources
Prevalence of central serous chorioretinopathy in Denmark. [PDF]
Acta OphthalmolAbstract Purpose Central serous chorioretinopathy (CSC) is a prevalent maculopathy, but epidemiological studies are few. In this study, we determined the prevalence of CSC for the first time in a Scandinavian population. Methods This cross‐sectional study was based on nationwide opportunistic retinal examination from 79 high street chain optician ...
Frederiksen IN +19 more
europepmc +2 more sources
Central Serous Chorioretinopathy [PDF]
Ophthalmologica, 2014 The pathogenesis of central serous chorioretinopathy (CSC) is still not fully understood. The involvement of corticosteroids is undisputed, although their exact role has not been clarified; other parts of the underlying mechanism of CSC have been mainly elucidated by imaging techniques such as fluorescein and indocyanine green angiography.
Liegl, Raffael, Ulbig, Michael W.
openaire +4 more sources
Central Serous Chorioretinopathy – an Overview [PDF]
Klinische Monatsblätter für Augenheilkunde, 2021 AbstractCentral serous chorioretinopathy (CSCR) is characterised by retinal serous detachment usually localised in the macular region. CSCR predominantly affects men between 30 and 50 years of age. Traditional classification differentiates between acute (duration shorter than 4 to 6 months) and chronic disease (duration longer than 4 to 6 months).
Berger, L., Bühler, V., Yzer, S.
openaire +2 more sources
Choroidal effusion as a manifestation of central serous chorioretinopathy: A case report
American Journal of Ophthalmology Case Reports, 2022 Purpose: To report a case of bullous central serous chorioretinopathy presenting with large choroidal effusions. Observations: A patient presented with typical features of bullous central serous chorioretinopathy with large choroidal effusions.
Tuan Tran +4 more
doaj +1 more source
Clinical Ophthalmology, 2013 Fabio Mazzolani,1 Stefano Togni21Private Ophthalmology Practice, 2Indena SpA, Milan, ItalyBackground: The therapeutic effects of Meriva®, a curcumin-phospholipid (lecithin) delivery system (formulated as Norflo® tablets), on visual acuity and ...
Mazzolani F, Togni S
doaj +3 more sources
Macular pigment optical density in central serous chorioretinopathy
Therapeutic Advances in Ophthalmology, 2021 Purpose: The aim of our study was to evaluate the macular pigment optical density in patients with acute and chronic central serous chorioretinopathy and to describe the association between central retinal thickness and choroidal thickness with the ...
Burcu Polat Gultekin, Esra Sahli
doaj +1 more source
Sleep and mood in central serous chorioretinopathy. [PDF]
Eye (Lond)Purpose: To investigate the impact of central serous chorioretinopathy on sleep and mood in patients with acute and chronic central serous chorioretinopathy.
Yang Y +7 more
europepmc +6 more sources